Skip to Main Content

Advertisement

Skip Nav Destination

Abstract A270: TAS-120, a highly potent and selective irreversible FGFR inhibitor, is effective in tumors harboring various FGFR gene abnormalities.

Mol Cancer Ther (2013) 12 (11_Supplement): A270.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Debroop Basu
  • Riya Pal
  • Maitrayee Sarkar
  • Soubhik Barma
  • Sumit Halder
  • Harekrishna Roy
  • Sisir Nandi
  • Asmita Samadder
Current Topics in Medicinal Chemistry (2023) 23 (30): 2877.
  • Ling Gao
  • Ikuo Yamamiya
  • Mark Pinti
  • Juan Carlos Rondon
  • Thomas Marbury
  • Gareth Tomlinson
  • Lukas Makris
  • Nanae Hangai
  • Volker Wacheck
Clinical and Translational Science (2023) 16 (9): 1713.
  • Subhasmita Mahapatra
  • Nisha Amarnath Jonniya
  • Suman Koirala
  • Kapil Dattatray Ursal
  • Parimal Kar
Journal of Biomolecular Structure and Dynamics (2023) 41 (22): 13509.
  • Gentry King
  • Milind Javle
Current Oncology Reports (2021) 23 (9)
  • Lipika Goyal
  • Sarinya Kongpetch
  • Valerie E. Crolley
  • John Bridgewater
Cancer Treatment Reviews (2021) 95: 102170.
  • Meng-di Dai
  • Yue-liang Wang
  • Jun Fan
  • Yang Dai
  • Yin-chun Ji
  • Yi-ming Sun
  • Xia Peng
  • Lan-lan Li
  • Yu-ming Wang
  • Wen-hu Duan
  • Jian Ding
  • Jing Ai
Acta Pharmacologica Sinica (2021) 42 (9): 1498.
  • Ryan A. Brawn
  • Andrew Cook
  • Kiyoyuki Omoto
  • Jiyuan Ke
  • Craig Karr
  • Federico Colombo
  • Milena Virrankoski
  • Sudeep Prajapati
  • Dominic Reynolds
  • David M. Bolduc
  • Tuong-Vi Nguyen
  • Patricia Gee
  • Deanna Borrelli
  • Benjamin Caleb
  • Shihua Yao
  • Sean Irwin
  • Nicholas A. Larsen
  • Anand Selvaraj
  • Xuesong Zhao
  • Stephanos Ioannidis
ACS Medicinal Chemistry Letters (2021) 12 (1): 93.
  • Mei Feng
  • Yisheng Pan
  • Ruirui Kong
  • Shaokun Shu
The Innovation (2020) 1 (2): 100032.
  • Rohan Garje
  • Josiah An
  • Mohammad Obeidat
  • Kranthi Kumar
  • Hesham A. Yasin
  • Yousef Zakharia
The Oncologist (2020) 25 (11): e1711.
  • R. Bahleda
  • F. Meric-Bernstam
  • L. Goyal
  • B. Tran
  • Y. He
  • I. Yamamiya
  • K.A. Benhadji
  • I. Matos
  • H.-T. Arkenau
Annals of Oncology (2020) 31 (10): 1405.
  • Maria Kalyukina
  • Yuliana Yosaatmadja
  • Martin J. Middleditch
  • Adam V. Patterson
  • Jeff B. Smaill
  • Christopher J. Squire
ChemMedChem (2019) 14 (4): 494.
  • Alberto Picca
  • Giulia Berzero
  • Franck Bielle
  • Mehdi Touat
  • Julien Savatovsky
  • Marc Polivka
  • Elena Trisolini
  • Sheida Meunier
  • Yohann Schmitt
  • Ahmed Idbaih
  • Khe Hoang-Xuan
  • Jean-Yves Delattre
  • Karima Mokhtari
  • Anna Luisa Di Stefano
  • Marc Sanson
Neurology (2018) 90 (23)
  • Rut Porta
  • Roberto Borea
  • Andreia Coelho
  • Shahanavaj Khan
  • António Araújo
  • Pablo Reclusa
  • Tindara Franchina
  • Nele Van Der Steen
  • Peter Van Dam
  • Jose Ferri
  • Rafael Sirera
  • Aung Naing
  • David Hong
  • Christian Rolfo
Critical Reviews in Oncology/Hematology (2017) 113: 256.
  • Antonella De Luca
  • Daniela Frezzetti
  • Marianna Gallo
  • Nicola Normanno
Expert Opinion on Investigational Drugs (2017) 26 (3): 303.
  • Jun Zhang
  • Yang Li
Seminars in Cell & Developmental Biology (2016) 53: 144.
  • Masaru Katoh
Trends in Pharmacological Sciences (2016) 37 (12): 1081.
  • Yasmine Tanner
  • Richard P. Grose
Seminars in Cell & Developmental Biology (2016) 53: 126.
  • Niamh Hallinan
  • Stephen Finn
  • Sinead Cuffe
  • Shereen Rafee
  • Kenneth O’Byrne
  • Kathy Gately
Cancer Treatment Reviews (2016) 46: 51.
  • Mehdi Touat
  • Ecaterina Ileana
  • Sophie Postel-Vinay
  • Fabrice André
  • Jean-Charles Soria
Clinical Cancer Research (2015) 21 (12): 2684.
  • Teresa Helsten
  • Maria Schwaederle
  • Razelle Kurzrock
Cancer and Metastasis Reviews (2015) 34 (3): 479.
Close Modal

or Create an Account

Close Modal
Close Modal